Automated chemiluminescence immunoassay (ChLIA) systems are nowadays a mainstay for many diagnostic laboratories. Euroimmun has joined forces with Immunodiagnostic Systems (IDS) to offer an extensive portfolio of diagnostic solutions based on ChLIA technology. Clinical Laboratory International talked to Dr. Anna Stanisak, Global Product Manager for Automation at Euroimmun to find out more.
Congratulations to Finlay MacKenzie and Dr Rachel Marrington of Birmingham Quality [one of the main providers of clinical biochemistry external quality assessment (EQA) schemes in the UK] on receipt of their Impact Award presented at this year’s LabMedUK meeting in Manchester. This prestigious award recognizes their outstanding work on patient-centric EQA for acute kidney injury […]
A global leader in liquid-stable reagents
Pioneering next-generation clinical diagnostics through innovation and sustainability
Although great developments have been made in treating lung cancer, it remains the most common cause of cancer deaths, largely because patients present late with advanced disease. Timely and accurate reporting of biomarker analysis is crucial for directing physicians to the most appropriate therapy for the patient. CLI chatted to Dr Brandon Sheffield (molecular pathologist […]
Iron deficiency and iron deficiency anemia are remarkably common worldwide. However, recommended ferritin cut-off concentrations can vary widely and there is room for improvement in standardization across different assay platforms. Dr Katie Troike and Dr Adam McShane (Department of Pathology and Laboratory Medicine, Cleveland Clinic, Cleveland, OH, USA) recently conducted their own re-evaluation of ferritin […]
A comprehensive review of diagnostic and monitoring strategies Delayed cerebral ischemia following aneurysmal subarachnoid hemorrhage is a multifactorial syndrome extending beyond large-vessel vasospasm. This review explores the evolving diagnostic and monitoring landscape, emphasizing a shift toward multimodal monitoring techniques that detect microcirculatory failure, spreading depolarizations, and metabolic distress.
Assessment of minimal residual disease during B-cell precursor acute lymphoblastic leukemia provides a good indication of therapy response and prognosis. This investigation can be done in several ways, including flow cytometry. Techniques in this field have developed in recent years and CLI chatted to Dr van der Velden (Department of Immunology, Erasmus University Medical Center, […]
For both the patient journey and laboratory efficiency, when diagnosing infectious diseases it is important to get it right and to get it right the first time. CLI caught up with Dr Gaiane Demirdjian, Director of Research & Development at Beckman Coulter Diagnostics, to find out more about how their new line of infectious disease […]
by Dr Jacqueline Gosink Bone turnover markers (BTMs) provide a non-invasive method to assess bone remodelling – the process by which old bone tissue is removed and replaced. Measurement of BTMs supports diagnosis of metabolic bone diseases, such as Paget’s disease, and is a useful aid for monitoring therapy responses in osteoporosis. Panels of peptide […]
March 2026
Prins Hendrikstraat 1
5611HH Eindhoven
The Netherlands
info@clinlabint.com
PanGlobal Media is not responsible for any error or omission that might occur in the electronic display of product or company data.